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Sox10 is a high-mobility-group transcriptional regulator
in early neural crest. Without Sox10, no glia develop
throughout the peripheral nervous system. Here we
show that Sox10 is restricted in the central nervous
system to myelin-forming oligodendroglia. In Sox10-de-
ficient mice progenitors develop, but terminal differen-
tiation is disrupted. No myelin was generated upon
transplantation of Sox10-deficient neural stem cells into
wild-type hosts showing the permanent, cell-autono-
mous nature of the defect. Sox10 directly regulates my-
elin gene expression in oligodendrocytes, but does not
control erbB3 expression as in peripheral glia. Sox10 thus
functions in peripheral and central glia at different stages
and through different mechanisms.
Received September 5, 2001; revised version accepted
November 20, 2001.
The strong expression of Sox10 in regions of the central
nervous system (CNS) such as corpus callosum and ce-
rebral and cerebellar white matter suggested predomi-
nant occurrence in glia (Kuhlbrodt et al. 1998b). To de-
termine the cell type expressing Sox10, we used a
Sox10
lacZ knock-in allele that faithfully reproduces
Sox10 expression in the mouse as -galactosidase expres-
sion (Britsch et al. 2001). X-Gal staining on sections of
adult Sox10
lacZ/+ mouse brain revealed that Sox10-ex-
pressing cells in the corpus callosum and in the cerebel-
lar white matter had the morphology and formed the
linear pearls-on-a-string arrays characteristic of oligo-
dendrocytes (Fig. 1a; data not shown). Oligodendrocyte-
and myelin-free regions such as the molecular layer of
the cerebellar cortex were not stained (data not shown).
Sox10 was also expressed in the adult optic nerve, which
contains astrocytes and oligodendrocytes but lacks nerve
cells. The optic nerve revealed an intense X-gal staining
with exception of its most retinal end, which is rich in
astrocytes and free of oligodendrocytes. Lack of -galac-
tosidase-positive cells in this region is therefore indica-
tive of selective Sox10 expression in oligodendrocytes
(Fig. 1b). Double immunolabelings in various brain re-
gions furthermore did not reveal a significant overlap
between the -galactosidase-expressing cell population
and cells positive for the pan-neuronal marker NeuN
(Fig. 1c) or the astrocytic marker glial fibrillary acidic
protein (GFAP; Fig. 1d). Amounts of -galactosidase were
highest in the somata of expressing cells. Lower levels in
the pertaining cellular processes colocalized with the oli-
godendrocytic markers O4, myelin-associated glycopro-
tein (MAG), proteolipid protein (PLP), myelin basic pro-
tein (MBP) or CNPase (Fig. 1e,f; data not shown). This
predominantly oligodendrocytic expression in the CNS
contrasts with the pan-glial expression of Sox10 in the
peripheral nervous system (PNS).
Sox10 expression in the oligodendrocyte lineage is not
restricted to the differentiated cell (Kuhlbrodt et al.
1998b; Zhou et al. 2000). In Sox10
lacZ/+ embryos, -ga-
lactosidase-positive cells were detected at 11.5 days post-
coitum (dpc) in a focal region in the ventral part of the
ventricular zone of the developing spinal cord, and ap-
proximately a day and a half later in the telencephalon at
the boundary between hypothalamus and ganglionic
eminence (data not shown). At these times, both regions
are known to give rise to oligodendrocyte progenitors (for
review, see Woodruff et al. 2001). Here we focus on the
spinal cord.
At 12.5 dpc, the number of Sox10-positive cells in the
ventral part of the ventricular zone had increased, and
some cells had started to emigrate from this region (Fig.
2a). Through 14.5 dpc and 16.5 dpc, some Sox10-positive
cells remained in the ventricular zone, the majority dis-
persed throughout the gray matter (Fig. 2b,c). This pat-
tern is characteristic of oligodendrocyte precursors as
evident from comparative in situ hybridizations on ad-
jacent sections with known markers for oligodendrocyte
precursors, such as olig2 (Fig. 2i–k) and PDGF receptor 
(Fig. 2q,r). In agreement with previous studies (Woodruff
et al. 2001), expression of olig2 and Sox10 precedes
PDGF receptor . Once expressed, PDGF receptor  la-
bels the same cells as Sox10/-galactosidase, as evident
from double immunohistochemistry (Fig. 2w–y). By 18.5
dpc, Sox10-positive cells began to accumulate in the pro-
spective white matter (Fig. 2d), where they start to ter-
minally differentiate and simultaneously lose PDGF re-
ceptor  expression (Fig. 2s). Olig2 is still expressed in
these cells (Fig. 2l).
Using age-matched Sox10
lacZ/Sox10
lacZ embryos, we
analyzed development of oligodendrocyte progenitors in
the absence of Sox10. Comparison of the expression pat-
terns of -galactosidase (Fig. 2e–h), olig2 (Fig. 2m–p), and
PDGF receptor  (Fig. 2t–v) failed to reveal significant
differences in the appearance, distribution, or number of
oligodendrocyte progenitors in homozygous Sox10-defi-
cient embryos at any time of embryonic development.
As judged from the intensity of the in situ hybridization
signal, there was a reduction in the expression levels for
PDGF receptor , indicating that its expression is influ-
enced by Sox10. In any case, levels of PDGF receptor 
were sufficient to guarantee progenitor generation and
survival. This result differs dramatically from the situa-
tion in the PNS of Sox10
lacZ/Sox10
lacZ embryos, where
glial progenitors are already absent (Britsch et al. 2001).
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the presumptive white matter of the spinal cord begin to
terminally differentiate and to express myelin genes
such as MBP, PLP, and MAG. Although these cells are
still few at 16.5 dpc in wild-type mice, their number rises
dramatically through 18.5 dpc until the day of birth (Fig.
3b–d for MBP; Fig. 3j–l for PLP; Fig. 3k, inset for MAG).
In age-matched Sox10
lacZ/Sox10
lacZ embryos, there are
no PLP-, MAG-, or MBP-positive cells at 16.5 dpc and at
18.5 dpc; even on sections of newborn homozygous mice
after 20 d gestation, we detected <5% of the MBP- or
PLP-positive cells found in wild-type littermates (Fig.
3f–h for MBP; Fig. 3n–p for PLP; Fig. 3o, inset for MAG).
This decrease does not appear to be due to apoptosis,
because we failed to detect an increase of TUNEL-la-
beled cells in the oligodendrocyte lineage at 18.5 dpc
(data not shown). In the CNS, Sox10 is one of the few
transcription factors restricted to the oligodendrocyte
lineage (Lu et al. 2000; Xu et al. 2000; Zhou et al. 2000).
Coexpression with other Sox proteins (Kuhlbrodt et al.
1998a) or dispensability of its target gene products during
early oligodendrocyte development may explain why its
role becomes apparent only at the onset of terminal dif-
ferentiation.
Homozygous Sox10-deficient mice die either before or
at birth (Britsch et al. 2001), making it impossible to
study the postnatal peak of terminal oligodendrocyte dif-
ferentiation and myelination. To circumvent this
problem, we performed transplantation experi-
ments. Neural stem cells were prepared from the
spinal cords of 12.5-dpc Sox10
lacZ/Sox10
lacZ em-
bryos and age-matched control littermates, ex-
panded as neurospheres, and injected as single-
cell suspensions in equal numbers into the reti-
nas of 3- to 9-day-old C57BL/6J recipient mice
(Ader et al. 2000). Intraretinal segments of gan-
glion cell axons are normally unmyelinated, but
can be experimentally myelinated by intraretinal
transplantation of myelinogenic cells (Laeng et
al. 1996; Ader et al. 2000). A fraction of intrareti-
nally grafted stem cells from wild-type donors
differentiated into oligodendrocytes in the vicin-
ity of the nerve fiber layer and had produced mas-
sive amounts of myelin 1 mo after transplanta-
tion. A myelinated nerve fiber layer was visible
already by macroscopic inspection of flat-
mounted retinas in 82% of host animals (data not
shown). Immunostaining of recipient retinas
with anti-MAGantibodies confirmed myelina-
tion by transplanted cells (Fig. 4a). MAG-immu-
noreactive axon fascicles were frequently de-
tected in the nerve fiber layer of recipient retinas
after sectioning (Fig. 4c). Stem cells from
Sox10
lacZ/Sox10
lacZ embryos, on the other hand,
failed to myelinate the host nerve fiber layer in a
total of 19 transplantations using four indepen-
dently prepared stem cell cultures, both when
analyzed macroscopically or by MAGimmuno-
histochemistry 1 mo or 2 mo after transplanta-
tion (Fig. 4b,d). A few residual MAG-positive
cells were found in two retinas transplanted with
stem cells from Sox10
lacZ/Sox10
lacZ embryos, in-
dicating that the block in terminal differentiation
is severe but not absolute.
We additionally transplanted stem cells de-
rived from control and Sox10
lacZ/Sox10
lacZ em-
bryos into the severely hypomyelinated brains of mice
deficient for MAGand the nonreceptor tyrosine kinase
Fyn (Ader et al. 2001). Grafting donor cells from
Sox10
lacZ/Sox10
lacZ embryos repeatedly produced no or
only residual MAGimmunoreactivity in MAG /Fyn-de-
ficient host brains 1 mo or 2 mo after transplantation
(Fig. 4h; data not shown). Transplantation of stem cells
from Sox10
lacZ/+ littermates, on the other hand, yielded
intense and widespread MAGimmunoreactivity in re-
cipient brains, indicative of the presence of numerous
donor-derived oligodendrocytes and myelin sheaths (Fig.
4f; data not shown).
We consistently observed a substantial number of
-galactosidase-positive cells in recipient tissues after
transplantation of Sox10
lacZ/Sox10
lacZ donor cells (cf.
Fig. 4e,i and Fig. 4g). Given the strong correlation of -ga-
lactosidase expression and oligodendrocyte fate, it ap-
pears likely that injected cells develop into oligodendro-
cyte progenitors, but fail to terminally differentiate, in-
stead persisting for a significant amount of time after
injection as progenitors. The failure of Sox10-deficient
neural stem cells to differentiate into myelinating oligo-
dendrocytes in a permissive environment proves that the
observed defect is cell-autonomous.
The loss of peripheral glia in Sox10-deficient mice has
previously been shown to be largely caused by disruption
of erbB3 expression and neuregulin signaling (Britsch et
Figure 1. Sox10 expression in the adult CNS. (a) X-Gal-stained section
from corpus callosum of an adult Sox10
lacZ/+ mouse. Linear arrays of
stained oligodendrocytes are marked by arrowheads. (b) Longitudinal sec-
tion of X-gal-stained optic nerve from an adult Sox10
lacZ/+ mouse. (c–f)
Immunohistological analysis of adult brain from Sox10
lacZ/+ mice using
antibodies against -galactosidase (green) in combination with various cell-
type-specific antibodies (red), including NeuN (c), GFAP (d), MBP (e), and
MAG( f). Pictures were taken at the following magnifications: 40× (b); 100×
(e,f); 200× (a); 400× (c,d).
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in oligodendrocytes shortly before terminal differentia-
tion (Canoll et al. 1996), raising the possibility that
Sox10 function in the oligodendrocyte lineage is also me-
diated by erbB3. In this case, homozygous erbB3-defi-
cient and homozygous Sox10-deficient embryos should
exhibit a similar oligodendrocyte phenotype. However,
myelin gene expression (MBP and PLP) at 18.5 dpc was
normal in the absence of erbB3 (Fig. 5a), and retinal
transplantation of stem cells from homozygous erbB3-
deficient embryos yielded normal amounts of myelin (D.
Reithmacher, M. Ader, M. Schachner, and U. Bartsch,
unpubl.). Additionally, spinal cord expression of erbB3
and erbB2 was comparable in Sox10-deficient and wild-
type embryos at 16.5 dpc and 18.5 dpc by various meth-
ods (Fig. 5b; data not shown). Taking a recent report into
account (Park et al. 2001), both neuregulin receptors and
Sox10 therefore appear to be essential for terminal dif-
ferentiation of oligodendrocytes, however, without the
genetic coupling found in peripheral glia.
As evident from the phenotype of the
MBP mouse mutant shiverer, loss of my-
elin gene expression is itself a potential
cause for terminal differentiation defects
in oligodendrocytes (Chernoff 1981;
Roach et al. 1985). In spinal cords of
Sox10
lacZ/Sox10
lacZ embryos, in situ hy-
bridization signals were already absent
at 14.5 dpc for the early MBP isoforms
and the alternatively spliced DM-20
transcript of the PLP gene at the focal
origin of oligodendrocyte precursors (Fig.
3, cf. a,i to e,m). In the absence of Sox10,
myelin gene expression is thus already
disturbed before the onset of terminal
differentiation, which supports the argu-
ment that disruption of myelin gene ex-
pression could itself be a cause of the
terminal differentiation defect.
Using a stable Neuro2A cell line with
tetracycline-dependent inducible Sox10
expression (Peirano et al. 2000), we ana-
lyzed for Sox10-dependent coinduction
of MBP and PLP. As evident from RT-
PCR analyses, expression of both genes
was significantly elevated in this heter-
ologous cell line in the presence of
Sox10, whereas expression of the
GAPDH control remained unaffected,
indicating that at least two major myelin
genes are under control of Sox10 (Fig.
5c). There was no up-regulation of MAG
under corresponding conditions (data
not shown).
In case of the MBP gene, a 3.2-kb frag-
ment from the 5 flanking region con-
tains all necessary elements to drive ex-
pression of a transgene in oligodendro-
cytes (Foran and Peterson 1992). The
same 3.2-kb fragment mediated a 10-fold
Sox10-dependent increase in luciferase
expression in transient transfections
(Fig. 5d). Most of the stimulatory activ-
ity was contained within the 256-bp re-
gion immediately adjacent to the tran-
scriptional start site. This proximal pro-
moter region is sufficient to drive oligodendrocyte-
specific transgene expression, albeit with reduced
efficiency and intensity (Goujet-Zalc et al. 1993). It con-
tained three binding sites for Sox10. Sites 2 and 3 were
bound by single Sox10 molecules and site 1 by two Sox10
molecules in a cooperative manner (Fig. 5e). As evident
from mutagenesis studies, site 1 consists of a high-affin-
ity consensus binding site and a low-affinity nonconsen-
sus element in identical orientation separated by 2 bp
(Fig. 5g,h). The low-affinity site was unable to bind
Sox10 by itself. Mutation of any one site led to a reduc-
tion of the MBP promoter’s responsiveness toward
Sox10, mutation of all three sites caused an almost com-
plete loss (Fig. 5f). Sox10 thus stimulates MBP expres-
sion by directly binding to multiple sites in the proximal
promoter region.
Binding behavior and action of Sox10 on the MBP pro-
moter is reminiscent of its function on the promoter of
the myelin protein zero (P0) gene in the PNS (Peirano et
al. 2000; Peirano and Wegner 2000). With P0, MBP, and
Figure 2. Sox10 expression and development of oligodendrocyte progenitors in the
embryonic spinal cord. X-gal staining (a–h) and in situ hybridizations with probes
specific for olig2 (i–p) or PDGF receptor  (q–v) were performed on transverse sections
from the forelimb region of embryos. (a–d) Sox10
lacZ/+ embryos. (i–l,q–s) Wild-type
embryos. (e–h,m–p,t–v) Sox10
lacZ/Sox10
lacZ embryos. (a,e,i,m) 12.5 dpc. (b,f,j,n,q,t)
14.5 dpc. (c,g,k,o,r,u) 16.5 dpc. (d,h,l,p,s,v) 18.5 dpc. Immunohistochemistry (w–y)o n
sections of 16.5-dpc Sox10
lacZ/+ embryos with antibodies against -galactosidase
(green) and PDGF receptor  (red) alone (w,x) and merged (y). Magnification 400×.
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genes at the transcriptional level, suggesting that Sox10
is a general regulator of myelin gene expression. Sox pro-
teins depend on cooperating transcription factors for full
activity (Wegner 1999; Kamachi et al. 2000). These as yet
unidentified cooperation partners may be responsible for
the difference in oligodendrocyte ver-
sus Schwann cell phenotype. They
may also explain the residual myelin
gene expression in a small percentage
of oligodendrocytes in Sox10-defi-
cient mice.
Sox10 is important in early neural
crest cells for development of mela-
nocytes and enteric nervous system
(Herbarth et al. 1998; Southard-Smith
et al. 1998; Kapur 1999; Britsch et al.
2001). Whereas these early neural
crest defects are already visible after
loss of a single allele as partial depig-
mentation and aganglionosis of the
colon, additional severe defects in pe-
ripheral gliogenesis become only vis-
ible in mice in the complete absence
of Sox10 function (Britsch et al. 2001).
The terminal differentiation failure of
oligodendrocytes reported here in ho-
mozygous Sox10-deficient mice char-
acterizes a further essential function
of Sox10.
Somewhat different from mice,
each of the functions of Sox10 is
manifested in patients carrying het-
erozygous Sox10 mutations. Nearly
all carriers of heterozygous Sox10
mutations show the typical signs of
pigmentation defects and agangliono-
sis of the colon summarized as
Waardenburg–Hirschsprung disease
(Pingault et al. 1998; Inoue et al. 1999; Southard-Smith et
al. 1999; Touraine et al. 2000; Korsch et al. 2001). Ap-
proximately 40% of all patients additionally exhibit
Charcot-Marie-Tooth type-1-like symptoms indicative
of peripheral myelinopathies, and a significant
10%–20% fraction suffers from Pelizaeus–Merzbacher
disease-like symptoms indicative of central my-
elinopathies, now explained by the role of Sox10
in oligodendrocyte development (Inoue et al.
1999; Southard-Smith et al. 1999; Touraine et al.
2000; Korsch et al. 2001). In humans, the different
rates of phenotypic manifestation in the hetero-
zygous state correlate with the time at which
Sox10 becomes essential in the affected cell lin-
eage. Although other possibilities can be envis-
aged, it is tempting to speculate that early func-
tions are less likely to be compensated by genetic
background and environmental cues than late
functions.
Materials and methods
Animal husbandry, genotyping, and transplantations
The Sox10
lacZ and erbB3
− mutations (Riethmacher et al. 1997;
Britsch et al. 2001) were kept on a C57BL/6J background. Geno-
typing was as described (Riethmacher et al. 1997; Britsch et al.
2001). Stem cell cultures from spinal cords of 12.5-dpc mouse
embryos were prepared and expanded as neurospheres in the
presence of epidermal growth factor and basic fibroblast growth
factor (Ader et al. 2000, 2001). Approximately 50,000 cells of
passage 2–4 were transplanted into retinas of 3- to 9-day-old
wild-type C57BL/6J as single-cell suspensions. For transplanta-
tion into brains of MAG/Fyn-deficient mice, ∼ 100,000 cells
were injected into the lateral ventricles of neonatal to 1-day-old
mice. Mice were killed 1 mo or 2 mo after transplantation, fixed
Figure 3. Expression of myelin genes in the embryonic spinal cord in the presence and
absence of Sox10. In situ hybridizations with probes specific for MBP (a–h), PLP (i–p), or
MAG( k,o, insets) were performed on transverse sections from the forelimb region of
embryos. (a–d,i–l) Wild-type embryos. (e–h,m–p) Sox10
lacZ/Sox10
lacZ embryos. (a,e,i,m)
14.5 dpc. (b,f,j,n) 16.5 dpc. (c,g,k,o) 18.5 dpc. (d,h,l,p) Newborn at 20 dpc. The in situ
hybridization signal at 14.5 dpc is marked by an arrowhead.
Figure 4. Neural stem cell transplantations. MAG-Immunohistochemis-
try (a–d,f,h) and X-gal staining (e,g,i) of wild-type retinas (a–e) and brain
sections from MAG/Fyn-deficient mice (f–i) 1 mo after transplantation
with stem cells derived from 12.5-dpc wild-type (a,c), Sox10
lacZ/+ (f,g), or
Sox10
lacZ/Sox10
lacZ (b,d,e,h,i) embryos. (a,b) Flat-mounted retinas. (c–e)V i -
bratome-sectioned retinas. (f–i) Corpus callosum. Arrows mark several
MAG-immunoreactive axon fascicles in the nerve fiber layer of a recipient
retina in c. Bars: b (for a and b), 50 µm; e (for c–e), 100 µm; i (for f–i), 200 µm.
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ing as described below.
In situ hybridization, X-gal staining, and immunohistochemistry
Embryos were obtained at 11.5–18.5 dpc from staged pregnancies. Para-
formaldehyde-fixed, 100-µm-thick vibratome sections or 10-µm-thick
cryotome sections of genotyped, age-matched mouse embryos, neonatals,
or adult mice were used for X-gal staining (Britsch et al. 2001) or in situ
hybridization according to standard procedures using DIG-labeled probes
for olig2, PDGF receptor , MAG, MBP, and PLP. Immunohistochemis-
try was carried out on 10-µm-thick cryotome sections of adult brain and
spinal cord using mouse monoclonal antibodies against O4, MBP, CN-
Pase, GFAP (all Roche Biochemicals), MAG (Ader et al. 2000), PDGF
receptor  (Pharmingen), and NeuN (Chemicon), in combination with
rabbit polyclonal antibodies against lacZ (ICN) as recommended by the
manufacturer. Secondary antibodies conjugated to Cy2 and Cy3 immu-
nofluorescent dyes (Dianova) were used for detection.
Tissue culture, transient transfections, RT-PCR, luciferase assays,
and gel shifts
Stable Neuro2A cells capable of expressing Sox10 in a tetracycline-in-
ducible manner were kept, treated with doxycycline, and used for RNA
preparation as described (Peirano et al. 2000). Detection of products spe-
cific for Sox10, PLP, MBP, MAG, erbB2, erbB3, and GAPDH in cDNA
generated by reverse transcription of RNA from these cells and embry-
onic tissue was by semiquantitative PCR. Luciferase reporter plasmids
were generated by cloning a 3.2-kb MBP promoter fragment as well as
several 5-shortened versions (see Fig. 5d) into the pGL2basic vector (Pro-
mega). Binding sites for Sox10 in the MBP promoter were inactivated by
changing them to GC-rich sequences using site-directed mutagenesis
(see Fig. 5h). Transient transfections of these reporters into the inducibly
Sox10-expressing Neuro2A cells and luciferase assays were performed as
described (Peirano and Wegner 2000). Electrophoretic mobility shift as-
says followed standard procedures using whole cell extracts containing or
devoid of the MIC variant of the Sox10 protein (amino acids 1–180) and
32P-labeled oligonucleotide probes containing Sox-binding sites from the
MBP promoter in wild-type or mutated version. Sequences of PCR prim-
ers and gel shift oligonucleotides are available on request.
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